Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

NANOMEDICINE - A GLOBAL MARKET REPORT   

Research Abstract

This report analyzes the Global Market for Nanomedicine in Millions of US$ by the following Application Areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials, and Others. Annual forecasts are provided for the period of 2006 through 2015. The report profiles 263 companies including many key and niche players worldwide such as Abraxis BioScience, Inc., Acusphere, Inc., Advion Biosciences, Inc., Agilent Technologies, Inc., AMAG Pharmaceuticals, Inc., Amgen, Inc., Arrowhead Research Corporation, Calando Pharmaceuticals, Inc., Nanotope, Inc., Tego BioSciences Corporation, BioForce Nanosciences, Inc., BioSante Pharmaceuticals, Inc., Crucell N.V., Elan Corporation Plc, Elan Drug Technologies, Ensysce Biosciences, Inc., Enzon Pharmaceuticals, Inc., eSpin Technologies, Inc., Flamel Technologies S.A., Johnson & Johnson, Life Technologies Corporation, Merck & Co., Inc., Nanobiotix, NanoCarrier Co., Ltd., Nanospectra Biosciences, Inc, Nanosphere, Inc., Nanosys, Inc., Nektar Therapeutics, Novavax, Inc., Oxonica Plc, Par Pharmaceutical Companies, Inc, pSivida Limited, Starpharma Holdings Limited, Dendritic Nanotechnologies, Inc., Starpharma Pty. Ltd., and Wyeth Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Code : MCP-1482
Price : $3950
Companies : 263
Pages : 698
Date : July 2009
Market Data Tables : 212

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  NANOMEDICINE (Complete Report) Pages : 698   | $3950
 
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS  
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2  
   Data Interpretation & Reporting Level.....I-3
Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Drug Delivery.....I-4
In Vitro Diagnostics.....I-4
In Vivo Imaging.....I-4
Biomaterials.....I-4
Others.....I-4
  
II. EXECUTIVE SUMMARY84$3000
  1. INDUSTRY OVERVIEW.....II-16 $700  
   Introduction.....II-1
Current and Future Analysis.....II-1
Industry Drivers.....II-1
1$100
   Industry Challenges.....II-21$100
   Developing World Ready to Adopt Nanomedicine in a Major Way.....II-3
India.....II-3
1$100
   China.....II-4
Japan.....II-4
Taiwan.....II-4
Nanotechnology Based Medical Products.....II-4
1$100
   Table 1: Global Nanomedicine Market (2007): Percentage Breakdown of Number of Nano-Based Products by Application Area - Drug Delivery, Biomaterials, In Vivo Imaging, and Others (includes corresponding Graph/Chart).....II-5
Nanotechnology Based Drug Delivery Products.....II-5
Table 2: Global Nanomedicine Market (2007): Percentage Breakdown of Number of Nano-Based Drug Delivery Products by Category - Liposomes, Nanocristals, Virosomes, and Others (includes corresponding Graph/Chart).....II-5
1$300
   Nanomedicine Patent Filings.....II-6
Table 3: Global Nanomedicine Market (1993-2003): Percentage Breakdown of Nanomedicine Patents by Application Area – Drug Delivery, In Vitro Diagnostics, Imaging, Biomaterials, and Others (includes corresponding Graph/Chart).....II-6

Table 4: Global Nanomedicine Market (1993-2003): Percentage Breakdown of Patents by Country - US, Germany, Japan, and Others (includes corresponding Graph/Chart).....II-6
1$300
  2. TRENDS & ISSUES.....II-710 $700  
   Nanomedicine - The Future Direction.....II-7
Transforming Healthcare Sector Generating Demand for Nanomedicine.....II-7
1$100
   Nanobiotechnology – A Promising Area.....II-8
High Demand for Tiny Healthcare Devices.....II-8
1$100
   Research in Nanomedicine Continues to Surge.....II-9
Nanotechnology in Healthcare to Sustain R&D Funding.....II-9
1$100
   Nanomedicine Clinical Pipeline to Sustain the Momentum.....II-10
Nanotechnology Gaining Ground in Fast Growing Drug Delivery Market.....II-10
1$100
   Nanotechnology – Generating More Enthusiasm Among Entrants.....II-111$100
   Demand for Supplies and Devices to Grow Rapidly.....II-12
Nanomedicine Needs Analysis of Ethical Implications.....II-12
Nanotechnology-based Drug Delivery Market on an Upbeat.....II-12
Nanotechnology Opens Up New Frontiers in Drug Discovery.....II-12
1$100
   Nanotechnology Raises Hope for Tuberculosis Treatment.....II-13
Demand for Nano-Based Medical Products to Rise Significantly.....II-13
Medical Nanorobotics to Raise the Standards.....II-13
1$100
   Nanomedicine – A Useful Element in Surgical Procedures.....II-14
Nano-based Diagnosis and Medical Imaging Helps Treatment of Critical Diseases.....II-14
1$100
   More Efficient Nanoparticles Could be Made Possible by Modeling Software.....II-151$100
   Major Issues Daunting Nanomedicine Sector.....II-16
1$100
  3. PRODUCT/TECHNOLOGY OVERVIEW.....II-177 $500  
   Nanomedicine - A Primer.....II-17
Nanopores.....II-17
Radio-Controlled Biomolecules.....II-17
1$100
   Quantum Dots.....II-18
Nanotubes.....II-18
1$100
   Fullerenes.....II-19
Nanoshells.....II-19
Nanoprobes.....II-19
Nanoparticles.....II-19
1$100
   Ceramic Nanoparticles.....II-20
Solid Lipid Nanoparticles.....II-20
1$100
   Nanocapsules.....II-21
Dendrimers.....II-21
Liposomes.....II-21
Micelles.....II-21
1$100
   Nanosuspensions.....II-22
Liquid Crystals.....II-22
Hydrogels.....II-22
Polymeric Nanoparticles.....II-22
1$100
   Molecularly Imprinted Polymers.....II-23
1$100
  4. APPLICATIONS.....II-249 $650  
   Drug Delivery.....II-241$100
   Targeted Nanodrug Delivery & Release.....II-25
Active and Passive Targeting Mechanisms in Drug Delivery.....II-25
Sustained and Pulsatile Release Mechanisms in Drug Delivery.....II-25
1$100
   In Vitro Diagnostics.....II-26
In Vivo Imaging.....II-26
Biomaterials.....II-26
Others.....II-26
Drugs and Therapy.....II-26
Active Medical Implants.....II-26
Oncology.....II-26
1$100
   Key Applications in Cancer Therapy.....II-27
Advanced Imaging, Early-Stage Detection, and Targeting.....II-27
1$100
   In-vivo Imaging.....II-28
Effective Tracking of Process Efficiency.....II-28
Advancing Bioinformatics and Proteomics Research.....II-28
Carbon Nanotubes in Cancer Treatment.....II-28
Regenerative Medicine.....II-28
1$100
   Futuristic Applications.....II-29
Bio-molecular Motors.....II-29
Genetic and Tissue Engineering.....II-29
External Tissue Products.....II-29
1$100
   Internal Tissue Implants.....II-30
Dental and Bone Replacement.....II-30
Protein and Gene Analysis.....II-30
Nanorobot Therapeutics.....II-30
1$100
   Lab-on-a-Chip Techniques.....II-311$100
   Medical Diagnostic Sensors.....II-32
Nano Medical Devices – From Surgical Tools to Contact Lenses.....II-32
Nanoengineered Prosthetics.....II-32
Nanotubes – Potential Drug Delivery Vehicles.....II-32
1$100
  5. NANOTECHNOLOGY – AN OVERVIEW.....II-335 $850  
   Building Blocks of Nanotechnology Used, Components and Final End-Use Products.....II-33
Global Nanotechnology Market.....II-33
1$100
   Table 5: Global Nanotechnology Market (2008 & 2009): Percentage Breakdown of Revenues by End-Use Segments – Chemicals, Automotive, Aerospace & Defense, Semi-Conductors & Electronics, Nanomedicine and Others (includes corresponding Graph/Chart).....II-34
Commercial Applications at an Embryonic Stage.....II-34
1$300
   Recent Commercial Applications of Nanotechnology.....II-351$100
   Nanotech Players – Germany Tops Europe While China Leads Asia-Pacific.....II-36
Table 6: Nanotech Companies in Europe (2007): Number of Players in Major Regional Markets - Germany, United Kingdom, Switzerland, France, and Sweden (includes corresponding Graph/Chart).....II-36
1$300
   Table 7: Nanotech Companies in Asia-Pacific (2007): Number of Players in Major Regional Markets - China, South Korea, Japan, Australia, and Taiwan (includes corresponding Graph/Chart).....II-37
Nanotech Funding by Regional Governments.....II-37
Table 8: Nanotech Funding by Regional Governments (2008): Leading National Markets Ranked by Funding in US$ Million for United States, Japan, Russia, Germany and China (includes corresponding Graph/Chart).....II-37
1$300
  6. TECHNOLOGICAL DEVELOPMENTS.....II-388 $550  
   German Scientists Develop Nanoparticle-Driven Gene Transfer Method.....II-38
Oxford Sees Progress in its Novel DNA Sequencing Technology Project.....II-38
Philips Releases First 3D Imaging Findings.....II-38
1$100
   Researchers in University of Pennsylvania Invent Novel Carbon Nanopipette.....II-39
UCLA Scientists Develop Localized and Controlled Drug Delivery Method.....II-39
1$100
   Minerva Makes New Discovery in Cancer Treatment.....II-40
NanoBio Releases Positive Data with NB-002.....II-40
1$100
   NanoBio Receives Positive Pre-Clinical Results with Intranasal Influenza
  Vaccine.....II-41
Abraxis Announces Interim Results of Abraxane® for Metastatic Breast Cancer.....II-41
Abraxis Reveals Positive Data with Abraxane® and Gemzar®.....II-41
1$100
   BioDelivery Commences Clinical Study with Bioral® Amphotericin B.....II-42
NanoCarrier Develops Protein Nanoencapsulation Technology.....II-42
Flamel Releases Positive Preliminary Data from FT-105 Phase I Study.....II-42
1$100
   Abraxis Releases Positive Pre-Clinical Data with nab™ Technology Platform and SPARC
  Expression in Cancer Treatment.....II-43
American Scientists Develop Unique Nano-Based Drug Delivery System.....II-43
Researchers at University of Queensland Focus to Develop Novel Nano-based Diagnostics
  for Cancer Detection.....II-43
1$100
   Indian Researchers Synthesize Polymeric Nanocurcumin for Cancer Therapy.....II-44
Researchers Mull on Using Nanoparticles to Develop Anti-Tumor Vaccines.....II-44
Nanomedicine Creates New Avenues for Regeneration of Nerve Cells.....II-44
1$100
   University of Illinois Develop Enhanced Biomimetic Membranes.....II-45
Johns Hopkins Faculty develop Nanoparticle-Embedded Microcapsules.....II-45
Max Planck Research Team Develops Gold Nanoparticles.....II-45
Nanotechnology based Panacea for Facial Wrinkles.....II-45
1$100
  7. PRODUCT INTRODUCTIONS/INNOVATIONS.....II-464 $400  
   Starpharma Holdings Releases the NanoJuice™ Transfection Kit.....II-46
Telomolecular Introduces Nano-Based Aging Solution.....II-46
CytoViva® Unveils Advanced Nanotechnology Research Tool.....II-46
1$100
   eBioscience Introduces eFluor™ Brand.....II-47
eBioscience Launches eFluor™ Nanocrystals.....II-47
BioForce Nanosciences Unveils Surface Patterning Service.....II-47
Eastman Kodak Unveils KODAK X-SIGHT Imaging Agents.....II-47
Biomet Launches NanoTite Dental Implant.....II-47
1$100
   Deerac Introduces Equator HTS/2 Liquid Handling Solution.....II-48
IMEC Develops Functionalized Magnetic Nanoparticles.....II-48
Ivoclar Vivadent Introduces New Version of Tetric Flow.....II-48
1$100
   Calando to Begin Human Clinical Trials for siRNA-based Therapeutic Drug for
  Cancer.....II-49
Dabur Pharma Launches Nano-Based Drug Delivery System.....II-49
1$100
  8. RECENT INDUSTRY ACTIVITY.....II-5022 $1100  
   APR Acquires New Drug Delivery Platform.....II-50
Merck Inks Merger Agreement with Schering-Plough.....II-50
Nanobiotix to Collaborate with SonoDrugs Project Consortium.....II-50
Liquidia and Abbott to Jointly Develop siRNA Therapeutics.....II-50
1$100
   Pro-Tect Acquires Medivices’ Nanotechnology Method.....II-51
APR to Create Dedicated Nanotechnology Unit.....II-51
Agilent Takes Over Nano Instruments.....II-51
Veridex Acquires Immunicon.....II-51
1$100
   Thermo Fisher Takes Over nAscent.....II-52
Labcyte and Deerac Fluidics Combine Operations.....II-52
Invitrogen and Applied Biosystems Merge to Form Life Technologies.....II-52
Insert Therapeutics Merges with Calando Pharmaceuticals.....II-52
1$100
   Capsulution Nanoscience and NanoDel Technologies Merge.....II-53
BioForce Forms Collaboration with UAlbany NanoCollege.....II-53
Advion and Bruker Daltonik Enter into Joint Marketing Agreement.....II-53
Midatech Group Inks Agreement with MonoSol Rx.....II-53
1$100
   Advion Signs Co-Marketing Agreement with Agilent Technologies.....II-54
Abraxis Inks Deal to Re-Acquire US Rights to Abraxane.....II-54
NanoKTN and Bio Nano to Develop Nanomedicine.....II-54
Evolved Machines Inks License Contract with Nanosys.....II-54
1$100
   Abraxis Bags European Commission Approval to Market Abraxane.....II-55
Nanogen Eyes European Molecular Diagnostics Market.....II-55
Abraxis Receives Approval for Marketing ABRAXANE in Korea and China.....II-55
BioForce Receives MIT Validation for Nano eNabler Molecular Printer.....II-55
Oxonica and Becton, Dickinson and Co. Sign Strategic Deal.....II-55
1$100
   Nanogen Sells Royalties to DRI Capital.....II-56
Nanogen Signs Deal with Thermo Fisher.....II-56
Midatech Establishes New Nanotechnology Subsidiary.....II-56
1$100
   Nanogen and HX Diagnostics Extend Collaboration.....II-57
CytImmune Joins Hands with University of Maryland.....II-57
Abraxis Inks Licensing Deal with Japan’s Taiho.....II-57
1$100
   Abraxis Files Marketing Application for Abraxane in Japan.....II-58
BioForce Secures State Funding for ViriChip™.....II-58
Capsulution and Advanced Materials Ink Patent License Deal.....II-58
1$100
   Midatech Bags US Grant on Patent Application.....II-59
Nanobiotix Wins European Patent for Activable Particles.....II-59
Nanotherapeutics Submits IND Application for NanoDOX ™ Hydrogel.....II-59
Nanobiotix to Focus on Development of Diagnostics for Tropical Diseases.....II-59
1$100
   Ceres to Develop Novel Nanotechnology Products.....II-60
Batist to Commence Production of Nanotechnology- Based Bandage.....II-60
Unidym Creates Spin-Off Unit.....II-60
1$100
   Avanti Creates Dedicated Targeted Drug Delivery Company.....II-61
Hill-Rom Chooses Anti-Microbial Technology of NanoHorizons.....II-61
Advion Acquires NanoTek.....II-61
Pioneer Surgical Acquires Angstrom Medica.....II-61
1$100
   Arrowhead Acquires C Sixty.....II-62
Veritek Completes Acquisition of Omni-Lite E-Form.....II-62
Wyeth Extends Collaboration with Ablynx.....II-62
Starpharma Inks Agreement with Stiefel.....II-62
1$100
   Nanosys Signs Collaboration Deal with Bruker Daltonics.....II-63
Abraxis Selects Green Cross to Commercialize Abraxane in Korea.....II-63
Abraxis Signs Deal to Partner California NanoSystems Institute.....II-63
1$100
   BioForce Nanosciences Inflates Clientele Base for Nano eNabler™ System.....II-64
Xidex Bags Contract to Make Carbon Nanotube Sources for Electron Microscopes.....II-64
Novartis Extends Deal with Ablynx.....II-64
BioSante Inks License Agreement with Medical Aesthetics.....II-64
1$100
   NanoImaging Launches Imaging Services Unit.....II-65
Midatech Inaugurates cGMP Standard Nanoparticles Production Facility.....II-65
Abraxis Announces Dedicated Proprietary Biotechnology Business.....II-65
1$100
   Eksigent Signs Distribution Deal in Brazil.....II-66
NanoVic Establishes Two Nano-bio Companies.....II-66
Veeco Signs Collaboration Deal with Leica.....II-66
1$100
   NanoViricides Inks CRADA with USDoD Agency.....II-67
Rexahn Wins Maryland Industrial Partnerships Funding.....II-67
Azaya Therapeutics Gains Patent for Nanotech-Based Cancer Treatment Platform.....II-67
Flamel Inks Deal with Wyeth Pharmaceuticals.....II-67
Flamel Signs Deal with Merck Serono.....II-67
1$100
   NanoChip® 400 Platform of Nanogen Now a GSA Schedule Product.....II-68
Nanogen Bags Canadian Funding for Veterinary and Bio-Terror Diagnostics Development
  Project.....II-68
Nanogen Signs Deal in Australia for Schizophrenia Markers.....II-68
1$100
   Wyeth Wins FDA Approval for New Labeling for Rapamune.....II-69
Arrowhead Infuses Capital into Tego.....II-69
GSK Extends Collaboration with Exelixis.....II-69
1$100
   Oncologix Collaborates with Dendritic Nanotechnologies to Redesign its Oncosphere
  Product.....II-70
Abraxis Signs Licensing Contract in India.....II-70
Abraxis Receives Australian TGA’s Acceptance to Review Marketing Application for
  Abraxane®.....II-70
1$100
   Nanotherapeutics and National Cancer Institute Sign CRADA.....II-71
Relisys and Cinvention Extend Licensing Agreement.....II-71
Lumera Extends Collaboration Pact with Medical University of South Carolina.....II-71
1$100
  9. FOCUS ON SELECT PLAYERS.....II-7211 $750  
   Abraxis BioScience, Inc. (US).....II-72
Acusphere, Inc. (US).....II-72
Advion Biosciences, Inc. (US).....II-72
Agilent Technologies, Inc. (US).....II-72
1$100
   AMAG Pharmaceuticals, Inc. (US).....II-73
Amgen, Inc. (US).....II-73
Arrowhead Research Corporation (US).....II-73
1$100
   Calando Pharmaceuticals, Inc. (US).....II-74
Nanotope, Inc. (US).....II-74
Tego BioSciences Corporation (US).....II-74
BioForce Nanosciences, Inc. (US).....II-74
1$100
   BioSante Pharmaceuticals, Inc. (US).....II-75
Crucell N.V. (The Netherlands).....II-75
Elan Corporation Plc (Ireland).....II-75
1$100
   Elan Drug Technologies (Ireland).....II-76
Ensysce Biosciences, Inc. (US).....II-76
Enzon Pharmaceuticals, Inc. (US).....II-76
eSpin Technologies, Inc. (US).....II-76
1$100
   Flamel Technologies S.A. (France).....II-77
Johnson & Johnson (US).....II-77
Life Technologies Corporation (US).....II-77
1$100
   Merck & Co., Inc. (US).....II-78
Nanobiotix (France).....II-78
1$100
   NanoCarrier Co., Ltd. (Japan).....II-79
Nanospectra Biosciences, Inc. (US).....II-79
Nanosphere, Inc. (US).....II-79
Nanosys, Inc. (US).....II-79
1$100
   Nektar Therapeutics (US).....II-80
Novavax, Inc. (US).....II-80
Oxonica Plc (UK).....II-80
Par Pharmaceutical Companies, Inc. (US).....II-80
1$100
   pSivida Limited (Australia).....II-81
Starpharma Holdings Limited (Australia).....II-81
Dendritic Nanotechnologies, Inc. (US).....II-81
Starpharma Pty. Ltd. (Australia).....II-81
1$100
   Wyeth Pharmaceuticals, Inc. (US).....II-82
1$100
  10. GLOBAL MARKET PERSPECTIVE.....II-83   
   Table 9: World Recent Past, Current & Future Analysis for Nanomedicine Market by Application Area – Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials and Other Applications Independently Analyzed with Annual Revenues in US$ Million for the Years 2006 through 2015 (includes corresponding Graph/Chart).....II-831$300
   Table 10: World 10-Year Perspective for Nanomedicine Market by Application Area – Percentage Breakdown of Revenues for Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials and Other Applications for the Years 2006, 2009 and 2015 (includes corresponding Graph/Chart).....II-841$300
III. COMPETITIVE LANDSCAPE 598$995
  
Total Companies Profiled: 263 (including Divisions/Subsidiaries - 269)

Region/Country                 Players


The United States                178
Canada                             9
Japan                              1
Europe                            58
     France                        6
     Germany                      17
     The United Kingdom           10
     Spain                         6 
     Rest of Europe               19 
Asia-Pacific (Excluding Japan)    15
Middle East                        8
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign